The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices

Neurovascular disorders are the second most leading causes of death worldwide after heart diseases. Statistical data suggest a high number of people are at an increased risk of developing neurological disorders due to the increasing incidences of lifestyle disorders and aging-related physiological problems in the geriatric populations. The increasing investments and expenditure on neurovascular therapy research and increasing awareness about minimally invasive procedures are boosting the demand for neurovascular devices. Neurovascular devices are based on numerous mechanisms of actions. Neurovascular devices used extensively include embolic coils, flow diversion devices, catheters, arterial stents, guidewires, liquid embolic agents, and others. These devices are often used to treat complex neurovascular disorders and to enhance patient outcomes.

The growth of the neurovascular devices market is majorly driven by the rising number of neurovascular surgeries, the increasing need for minimally invasive procedures, advancements in healthcare infrastructure, and the availability of favorable reimbursement policies. Moreover, the increasing incidences of traumatic brain injury, cerebral aneurysm, and brain stroke are expected to fuel the growth of the market over the coming years. The rising prevalence of the above-mentioned conditions is expected to add traction to the expansion of cerebral embolization and aneurysm coiling devices segment. The advent of advanced therapeutic and diagnostic technology and the benefits and safety offered by microcatheter and microguide wires are further propelling the adoption and growth of the neurovascular devices market. The high prevalence of hypertension, smoking, and increasing initiatives by the government and healthcare facilities to raise awareness is further anticipated to boost the market growth.

Some of the key players operating in the market are W. L. Gore & Associates, Inc., Abbott Laboratories, Terumo Corp., Merit Medical Systems, Inc., Penumbra, Inc., Medtronic Plc, Stryker Corp., MicroPort Scientific Corp., Johnson & Johnson, and others. The prominent players of the industry are focusing on the design and development of innovative neurovascular devices and strategic alliances to gain a substantial footing in the market. In 2019, Medtronic launched ai8 Phenom 21 Catheter, a neurovascular device that dissolves blood clots from the obstructed vessels of the brain to restore the normal circulation of blood in patients with large vessel occlusion. In September 2020, Johnson & Johnson Medical Devices Company’s subsidiary, CERENOVUS launched CERENOVUS Stroke Solutions™ consisting of 3 devices designed to assist the doctors during clot removal procedures.

In July 2020, medical imaging AI specialist, Avicenna, received a clearance from the U.S. FDA for its CINA Head Triage AI solution for neurovascular emergencies. The approval covers the capability of CINA to automatically detect large vessel occlusion and intracranial hemorrhage from images of CT scans.

Read full press release at: https://www.reportsanddata.com/press-release/global-neurovascular-devices-market 

Rising Prevalence of Acute Ischemic Conditions Propels the Acute Ischemia Monitors Market Growth

Acute ischemia is a condition where the blood flow to a particular organ or part of the body is restricted or reduced. Ischemia can typically occur anywhere in the body, and the two significant examples of ischemia are heart attacks and brain strokes. Ischemic stroke is a neurological emergency that can be reversible if treated at the right time. Ischemic heart disease causes the coronary arteries to narrow, restricting blood and oxygen availability to the heart muscles. Sudden restriction in the blood flow causes acute ischemia and is an emergent medical condition. Advancement in the field of heart monitoring devices and their alteration to monitor acute ischemia is driving the adoption of acute ischemia monitors across the globe.

The market is primarily driven by the rising development of the healthcare infrastructure, increasing incidences of acute ischemia, and the technological advancements in heart monitor devices. The advent of insertable monitors and the rising health complications are propelling the adoption of ischemic heart monitors. Moreover, the increasing levels of stress and sedentary lifestyle is increasing the incidences of acute ischemic conditions, which is, in turn, driving the growth of the market. Furthermore, the surge in awareness of acute ischemia complications, as well as other cardiovascular complications, is also anticipated to boost the market growth. With the rising number of cardiovascular surgical interventions and increasing traffic in the emergency room, the adoption of ischemic monitors such as benchtop monitors or portable monitors has witnessed a massive surge. Additionally, favorable reimbursement policies and advancement in the diagnostic techniques are anticipated to bolster the market's growth over the projected timeline.

With rapid advancements in the medical technology and healthcare infrastructure, coupled with soaring medical tourism, the Asia Pacific market is anticipated to expand significantly during the forecast period. The mounting prevalence of acute ischemic conditions is propelling the demand for advanced diagnostic and surgical techniques, thereby driving the market's growth in the region. The rising senior and general population and the emergence of state-of-the-art healthcare infrastructure across India and China contribute to the growth of the market in APAC.

Some of the prominent players of the acute ischemia monitors industry are Alfred Health Victoria Company, Angel Medical Systems Inc., Blue Box Health Inc., Boston Scientific Corp, Cardiowatch Ltd., Flashback Technologies, Inc., Intersection Medical, Inc., Medtronic plc, and Scivanta Medical Corp. In October 2020, Apollo Hospitals Group announced a partnership with India Medtronic, a wholly-owned subsidiary of Medtronic Plc, to incorporate an artificial intelligence platform for ischemic stroke management that will offer an analysis of the stroke in less than two minutes.

Read full press release at: https://www.reportsanddata.com/press-release/global-acute-ischemia-monitors-market